BamSEC and AlphaSense Join Forces
Learn More

Fulgent Genetics Inc.

NASDAQ: FLGT    
Share price (11/22/24): $17.87    
Market cap (11/22/24): $547 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.41
from 10-K 5 pages Rule 10b5-1 Issuer Repurchase Plan
12/34/56
EX-10.2
from 10-Q 6 pages Fulgent Genetics, Inc. Amended and Restated Executive Officer Incentive Plan Effective October 30, 2023
12/34/56
EX-10.1
from 10-Q 6 pages Fulgent Genetics, Inc. Amended and Restated Incentive Compensation Recoupment Policy
12/34/56
EX-10.1
from 8-K 13 pages Fulgent Genetics, Inc. Amended and Restated 2016 Omnibus Incentive Plan
12/34/56
EX-10
from 10-Q 5 pages Fulgent Genetics, Inc. Executive Officer Incentive Plan Effective January 1, 2023
12/34/56
EX-10
from 10-Q 3 pages Fulgent Genetics, Inc. Amended and Restated Director Compensation Program
12/34/56
EX-10
from 10-K 13 pages Fulgent Pharma Holdings, Inc. 2022 Omnibus Incentive Plan
12/34/56
EX-10
from 10-K 45 pages Lease of Premises at 15-19 Crawford Street Needham, Massachusetts From Crawford Street De, LLC to Miraca Life Sciences, Inc
12/34/56
EX-10
from 10-K 4 pages Second Amendment to Lease
12/34/56
EX-10
from 10-K 11 pages First Amendment and Partial Restatement of Lease
12/34/56
EX-10
from 10-K 12 pages Background: 1. Incorporation. the Above Background Is Incorporated Herein by Reference
12/34/56
EX-10
from 10-K 5 pages Rule 10b5-1 Issuer Repurchase Plan
12/34/56
EX-10.3
from 10-Q 73 pages Agreement and Plan of Merger by and Among Fulgent Genetics, Inc., Fg Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the Stockholders Set Forth Herein November 7, 2022
12/34/56
EX-10.2
from 10-Q 6 pages Fulgent Pharma Holdings, Inc. 2022 Omnibus Incentive Plan Notice of Restricted Stock Unit Award
12/34/56
EX-10.1
from 10-Q 3 pages Fulgent Genetics, Inc. Amended and Restated Director Compensation Program
12/34/56
EX-10.1
from 8-K 3 pages Fulgent Genetics, Inc. Incentive Compensation Recoupment Policy
12/34/56
EX-10.41
from 10-K 33 pages Amended and Restated Lease by and Between Store Master Funding IX, LLC as Landlord and Cytometry Specialists, Inc., as Tenant. May 6, 2016
12/34/56
EX-10.1
from 10-Q 31 pages Pursuant to Item 601(b)(10) of Regulation S-K, Certain Confidential Portions of This Exhibit Have Been Omitted by Means of Marking Such Portions With Asterisks as the Identified Confidential Portions (I) Are Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Restructuring Agreement of Fujian Fujun Gene Biotech Co., Ltd
12/34/56
EX-10.1
from 10-Q 3 pages Fulgent Genetics, Inc. Amended and Restated Director Compensation Program
12/34/56
EX-10.38
from 10-K 9 pages Severance Agreement
12/34/56